In Focus channel feed – Endpoints News

In Focus channel feed

With HIV prevention under attack, how might Gilead’s new PrEP injection fare?

2 days ago

Have sky-high sales projections set the obesity market up to fail?

4 days ago

Exclusive: Rebooting dead human brains, a biotech startup seeks to reinvent early drug testing work

5 days ago

Struggling biotechs succumb to icy market, as money dries up and clinical bets don’t pay off

Last week

DNA giant Illumina spawned an ecosystem of competitors and customers

3 weeks ago

A new dawn for psychedelics? Compass could be the first to find out

3 weeks ago

Big leases, bigger regrets: Biotech slump turns swanky offices from asset into liability

4 weeks ago

The inside story of the six-month sprint to create the first custom CRISPR therapy for one infant’s rare disease

5 weeks ago

Exclusive: Drug compounder Empower was built on risky shortcuts, ex-employees and inspections allege

Last month

'Find a way, or make one': How two scientists hope to revitalize CRISPR's rare disease crisis

Last month

The inside story of how SalioGen, a startup trying to wrangle ‘jumping genes’ to make medicines, fell apart

Last month

US drugmakers increasingly look abroad for clinical trials as confidence in FDA wavers

Last month

Primate researchers cope with uncertainty as NIH appeals for payment cuts in court

2 months ago

‘People will die’: End of NIH grants guts work between academics and companies to counter next pandemic

2 months ago

Illumina was built on DNA. Its future could be biology’s next big wave

2 months ago

A California health tech company is letting AI run medical visits, from intake to diagnosis

2 months ago

Ahead of FDA decision, Alnylam faces the big question: Can it make money?

2 months ago

Inside NYC’s waitlist-only health tech club, where young professionals find both friends and jobs

3 months ago

Trump’s science crackdown hits rare disease research: ‘We need to sit down with Elon Musk’

3 months ago

Can Bill Anderson save Bayer?

3 months ago

Will CRISPR matter?

3 months ago

Drugmakers seize on biomarkers to test the FDA's rare disease shift

4 months ago

Trump blog: Federal agencies must give jobs back to fired probationary workers, judge rules

4 months ago

China's biotech boom is threatening US drugmakers' dominance

4 months ago

12 3 4 Next page Last page